What is the recommended dosage of amoxicillin (Amoxicillin) for the treatment of Acute Otitis Media (AOM)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amoxicillin Dosage for Acute Otitis Media (AOM)

High-dose amoxicillin at 80-90 mg/kg/day divided into two doses is the recommended first-line treatment for acute otitis media. 1

First-Line Treatment Options

  • Standard recommendation: Amoxicillin 80-90 mg/kg/day divided into two doses for children
  • Duration:
    • 10 days for children under 2 years or those with severe symptoms
    • 7 days for children 2-5 years with mild/moderate AOM
    • 5-7 days for children 6 years and older with mild/moderate symptoms 2, 1

Treatment Algorithm

Clinical Scenario Recommended Treatment
First episode of AOM High-dose amoxicillin (80-90 mg/kg/day in 2 divided doses)
Recent amoxicillin use (within 30 days) Amoxicillin-clavulanate (90 mg/kg/day of amoxicillin with 6.4 mg/kg/day of clavulanate in 2 divided doses)
Concurrent conjunctivitis Amoxicillin-clavulanate (90 mg/kg/day of amoxicillin with 6.4 mg/kg/day of clavulanate in 2 divided doses)
Treatment failure after 48-72 hours Switch to amoxicillin-clavulanate or consider ceftriaxone

Rationale for High-Dose Amoxicillin

High-dose amoxicillin is preferred over standard-dose (40-45 mg/kg/day) because:

  1. It achieves middle ear fluid levels that exceed the minimum inhibitory concentration (MIC) of intermediately resistant S. pneumoniae (penicillin MICs 0.12-1.0 μg/mL) and many highly resistant serotypes (penicillin MICs ≥2 μg/mL) 2

  2. It demonstrates improved bacteriologic and clinical efficacy compared to regular dosing, particularly against resistant pneumococcal strains 2

  3. Current US data indicate approximately 87% of S. pneumoniae isolates are susceptible to high-dose amoxicillin compared to 83% for regular-dose amoxicillin 2

Special Considerations

  • Beta-lactamase producing organisms: For patients with recent amoxicillin use, concurrent conjunctivitis, or when coverage for M. catarrhalis is desired, use high-dose amoxicillin-clavulanate (90 mg/kg/day of amoxicillin with 6.4 mg/kg/day of clavulanate) 2, 1

  • Penicillin allergies:

    • Non-Type I allergies: Cefdinir (14 mg/kg/day), cefuroxime (30 mg/kg/day), or cefpodoxime (10 mg/kg/day)
    • Type I allergies: Macrolides (e.g., azithromycin) or clindamycin (30-40 mg/kg/day) 2, 1
  • Dosing frequency: While the traditional recommendation is twice-daily dosing, research suggests that once or twice daily dosing of amoxicillin is comparable to three-times daily dosing in terms of clinical efficacy and compliance 3

Monitoring and Follow-up

  • Assess response to therapy within 48-72 hours
  • If no improvement occurs within this timeframe:
    1. Confirm diagnosis
    2. Switch to amoxicillin-clavulanate
    3. Consider referral to ENT specialist, especially with tympanic membrane perforation 1

Common Pitfalls to Avoid

  1. Underdosing amoxicillin: Using standard-dose (40-45 mg/kg/day) instead of high-dose (80-90 mg/kg/day) may be inadequate for resistant S. pneumoniae, particularly during viral coinfection 4

  2. Failure to recognize treatment failure: Not switching antibiotics when there's no improvement after 48-72 hours of treatment

  3. Inappropriate observation strategy: Children under 2 years with bilateral AOM require immediate antibiotic therapy rather than observation 1

  4. Inadequate treatment duration: Using shorter courses (5-7 days) in children under 2 years or those with severe symptoms instead of the recommended 10 days 2, 1

  5. Not considering beta-lactamase producers: Failing to use amoxicillin-clavulanate when there's recent amoxicillin use or concurrent conjunctivitis 5

The evidence strongly supports high-dose amoxicillin as first-line therapy for AOM, with appropriate adjustments based on clinical factors and response to treatment.

References

Guideline

Otitis Media Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.